Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need

por Cherian, Neil, Bettis, Alison, Deol, Arminder, Kumar, Arun, Di Fabio, Jose Luis, Chaudhari, Amol, Yimer, Solomon, Fahim, Raafat, Endy, Timothy
Publicado 2023

The efficacy and safety of a nicotine conjugate vaccine (NicVAX(®)) or placebo co-administered with varenicline (Champix(®)) for smoking cessation: study protocol of a phase IIb, d...

por Hoogsteder, Philippe HJ, Kotz, Daniel, van Spiegel, Paul I, Viechtbauer, Wolfgang, Brauer, Ruth, Kessler, Paul D, Kalnik, Matthew W, Fahim, Raafat EF, van Schayck, Onno CP
Publicado 2012

Immunogenicity and Smoking Cessation Outcomes for a Novel Nicotine Immunotherapeutic

por Hatsukami, Dorothy K., Jorenby, Douglas E., Gonzales, David, Rigotti, Nancy A., Glover, Elbert D., Oncken, Cheryl A., Tashkin, Donald P., Reus, Victor I., Akhavain, Roxanne C., Fahim, Raafat E.F., Kessler, Paul D., Niknian, Minoo, Kalnik, Matthew W., Rennard, Stephen I.
Publicado 2011